The developmental stage-specific silencing of the human ε-globin gene during embryonic life is controlled, in part, by the silencer (-392bp ~-177bp) upstream of this gene. In order to elucidate its role, the nuclear extract from the human fetal liver has been prepared and the interactions between transacting factors and this silencer element have been examined. By using DNaseI footprinting assay, a major protected region from-278bp to-235bp within this silencer element was identified. Furthermore, we found in gel mobility shift assay and Southwestern blotting assay that there were at least four transacting factors (MW ≈ 32, 28, 26 and 22kD) in the nuclear extract isolated from the human fetal liver, which could specifically bind to this region. Our results suggested that these transacting factors might play an important role in silencing the human embryonic ε-globin gene expression at the fetal stage through the interactions with this silencer.